Interferon alpha and omega antibody antagonists
US10155809B2 · kind B2 · utility
0Cited by
13References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2017 |
| Grant date | Dec 18, 2018 |
| Priority date | — |
| Expiry date | Sep 18, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Broadly neutralizing interferon-α and interferon-ω antibody antagonists, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of diseases associated with increased production of IFNα and IFNω.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.